Frailty and sarcopaenia are commonly used terms in the medical management of older people but their relationship to those with diabetes has not been explored in great detail. In this review, we hypothesise that diabetes and frailty are related conditions, and we attempt to explain the nature of this relationship, and consider the possibility that sarcopaenia is an intermediate step.
MorleyJE. Diabetes and aging: Epidemiologic overview. Clin Geriatr Med2008;24:395-405.
2.
RockwoodKTanMHPhillipsSMcDowellI. Prevalence of diabetes mellitus in elderly people in Canada: report from the Canadian Study of Health and Aging. Age and Ageing1998;27:573-7.
3.
FriedLPFerruciLDarerJ. Understanding the concepts of disability, frailty and comorbidity: implications for improved targeting and care. J Gerontol Biol Sci Med Sci2004;59:255-63.
4.
RockwoodKHowlettSEMacKnightC. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and anging. J Gerontol A Biol Sci Med Sci2004;59:1310-7.
5.
WoodsNFLacroixAZGraySL. Frailty: emergence and consequences in women aged 65 and older in the women’s Health Initiative Observational Study. J Am Geriatr Soc2005;53:1321-30.
BautmansIVanPuyveldeMetsT. Sarcopenia and functional decline: pathophysiology, prevention and therapy. Acta Clinic Belgica2009;64:303-16.
8.
SinclairAJMeneillyGS. Type 2 diabetes mellitus in senior citizens. In: John PathyMSSinclairAJMorleyJE (eds). Principles and Practice of Geriatric Medicine. 4 ed.Chichester: Wiley, 2006:1431-45.
9.
RockwoodKAwaltEMacKnightCMcDowellI. Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging. CMAJ2000;162:769-72.
10.
SinclairAJ. Diabetes in elderly: a perspective from the United Kingdom. Clin Geriatr Med1999;15:225-37.
11.
Standards of Medical Care in Diabetes. American Diabetes Association. 2011;34.
12.
MorleyJEKimMJHarenMT. Frailty and hormones. Rev Endocr Metab Disord2005;6:101-08.
13.
RoubenoffRHughesVA. Sarcopenia: current concepts. J Gerontol A Biol Schi Med Sci2000;55:716-24.
14.
VandervoortAA. Aging of the human neuromuscular system. Muscle Nerve2002;25:17-25.
15.
FronteraWRHughesVALutzKJEvansWJ. A cross-sectional study of muscle strength and mass in 45 to 78 years old men and women. J Appl Physiol1991;71:644-50.
16.
DelaFKjaerM. Resistance training, insulin sensitivity and muscle function in the elderly. Essays Biochem2006;42:75-88.
17.
JansenIBaumgartnerRNRossR. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol2004;159:413-21.
18.
CesariMLeeuwenburghCLauretaniF. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr2006;83:1142-8
19.
RockwoodKStadnykKMacknightC. A brief clinical instrument to classify frailty in elderly people. Lancet1999;353;205-6.
20.
FriedLPTangenCMWalstonJ. Frailty in older adults: evidence for a phenotype. J Gerontol A Bio Sci Med Sci2001;56:46-56.
21.
HoganDBMacknightCBergmanH. Models, definitions, and criteria of frailty. Aging Clin Exp Res2003;15:1-29.
22.
ParkSWGoodpasterBHStrotmeyerES. Decreased muscle and quality in older adults with type 2 diabetes. Diabetes2006;55:1813-8.
23.
ParkSWGoodpasterBHStrotmeyerES. Accelerated loss of skeletal muscle strength in older adults with db 2. Diabetes Care2007;30:1507-12.
24.
ParkSWGoodpasterBHLeeJSKullerLH. Health, Aging, and Body Composition Study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care2009;32:2136-7.
25.
AndersenHNielsenSMogensenCEJakobsenJ. Muscle strength in type 2 diabetes. Diabetes2004;53:1543-8.
26.
NomuraTIkedaYNakaoS. Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocrine2007;54:791-6.
27.
BrooksNLayneJEGordonPL. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci2006;4:19-27.
28.
SayerAASyddallHEDennisonEM. Hertfordshire Cohort. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM2007;100:707-13.
29.
SyddallHCooperCMartinF. Is grip strength a useful single marker of frailty?Age Ageing2003;32:650-6.
30.
OttenbacherKJOstirGVPeekMK. Frailty in older Mexican Americans. J Am Geriatr Soc2005;53:1524-31.
31.
SayerAADennisonEMSyddallHE. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg?Diabetes Care2005;28:2541-2.
32.
BaumgartnerRNWaltersDL. Sarcopenia and sarcopenic-obesity. Principles and Practice of Geriatric Medicine. Pathy MSJ ed. United Kingdom. 2006.
33.
MacIntoshCMorleyJEChapmanIM. The anorexia of aging. Nutrition2000;16:983-95.
34.
MorleyJESilverAJ. Anorexia in the elderly. Neurobiol Aging1988;9: 9-16.
35.
KhanMSChandanpreetSKewalK. Malnutrition, anthropometric, and biochemical abnormalities in patients with diabetic nephrophaty. J Ren Nutr2009;19:275-82.
36.
MatthewCRobertCAaronS. The prevalence of vitamin B12 Deficiency in patients with type 2 diabetes: a cross sectional study. J Am Board Fam Med2009;22:528-34.
37.
CapolaARXueQLFriedLP. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the women’s health and aging studies. J Gerontol A Biol Sci Med Sci2009;64:243-8.
38.
SparkRF. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep2007;8:467-71.
39.
OzfiratZTahseenAC. Vitamin D deficiency and type 2 diabetes. Postgrad Med J2010;86:18-25.
40.
Moreira-PfrimerLDPedrosaMATeixeiraL. Treatment of vitamin D deficienciy increases lower limb muscle strenth in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab2009;54:291-300.
41.
LehrkeMBroedlUCBiller-FriedmannIM. Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions. Crit Care2008;12:R157.
42.
ShaapLAPluijmSMFDeegDJVisserM. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med2006;119:526.e9-17.
43.
SunYAsnicarMSmithRG. Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology2007;86:215-28.
44.
AbbatecolaAMPaolisSoGLamponiM. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc2004;52: 1713-18.
45.
RoubenoffRPariseHPayetteHA. Cytokine, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med2003;115:429-35.
46.
HalvatsiotisPShortKRBigelowM. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes2002;51:2395-404.
47.
FigaroMKKritchevskySBResnickHE. Diabetes, inflammation and functional decline in older adults. Diabetes Care2006;29:2039-45.
48.
PutsMTVisserMTwiskJWR. Endocrine and inflamatory markers as predictors of frailty. Clin Endocrinol2005;63:403-11.
49.
BarzilayJIBlaumCMooreT. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med2007;167:635-41.
50.
BatesCJLeanMEMansoorMA. Nutrient intakes: biochemical and risk indices associated with type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Diabet Med2004;21:677-84.
51.
WatersDLBaumgartnerRN. Sarcopenia and obesity. Clin Geriatr Med2011;27:401-21.
52.
RodenM. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Intern J Obes2005;29:S111-15.
53.
YokotaTKinugaSHirabayashiK. Oxidative stress in skeletal mucle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice. Am J Physiol Heart Circ Physiol2009;297:h1069-77.
54.
HaidiARJassimAI. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag2007;3:853-76.
55.
SembaRDBandinelliSSunK. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults. Eur J Appl Physiol2010;108:191-5.
